Healthcare -
Biotechnology - NASDAQ - US
$ 358.93
-2.04 %
$ 16 B
Market Cap
15.78
P/E
UTHR - LONG-TERM DEBT
Long-term Debt UTHR - United Therapeutics Corporation
300 M
LAST VALUE
-38.76%
2 YEAR CAGR
3.71%
5 YEAR CAGR
55.10%
10 YEAR CAGR